Bosulif (bosutinib)

pCPA File Number: 21160
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Myeloid Leukemia
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
pCODR RFA 0002
pCPA Engagement Letter Issued:
Negotiation Process Concluded: